Table 10.
EPIAO®/EPREX® treatment for 12 mo and baseline hemoglobin level.
| EPIAO® (N = 68) | EPREX® (N = 69) | P value | 95% CI | |||||
|---|---|---|---|---|---|---|---|---|
| Index | Baseline | 12 mo | Difference | Baseline | 12 mo | Difference | Confidence interval | |
| Hemoglobin (g/dL) | ||||||||
| Mean (SD) | 11.18 (0.57) | 11.24 (0.89) | 0.04 (1.11) | 11.29 (0.52) | 11.28 (0.73) | −0.01 (0.87) | ||
| Median (Q1~Q3) |
11.2 (10.7~11.7) |
11.2 (10.7~11.87) |
−0.05 (−0.6~0.9) |
11.3 (10.9~11.8) |
11.3 (10.85~11.6) |
0.1 (−0.6~0.6) |
||
| Min~Max | 10~12.3 | 9.3~13.4 | −2.9~2.5 | 10.2~12.3 | 9.3~13.5 | −1.9~2.4 | ||
| Hemoglobin level difference | .85 | −0.02 (−0.3, 0.25) | ||||||